azathioprine has been researched along with Hypertriglyceridemia in 5 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Hypertriglyceridemia: A condition of elevated levels of TRIGLYCERIDES in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dosing of these agents was concentration-controlled and open-labeled." | 2.71 | Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study. ( Bäckman, L; Brattström, C; Calne, R; Campistol, JM; Charpentier, B; Claesson, K; Durand, D; Groth, CG; Kreis, H; Lang, P; Morales, JM; Touraine, JL; Wramner, L, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charpentier, B | 1 |
| Groth, CG | 2 |
| Bäckman, L | 1 |
| Morales, JM | 1 |
| Calne, R | 1 |
| Kreis, H | 1 |
| Lang, P | 1 |
| Touraine, JL | 1 |
| Claesson, K | 1 |
| Campistol, JM | 1 |
| Durand, D | 1 |
| Wramner, L | 1 |
| Brattström, C | 2 |
| Pannu, HS | 1 |
| Singh, D | 1 |
| Sandhu, JS | 1 |
| Wilczek, HE | 1 |
| Tydén, G | 1 |
| Böttiger, Y | 1 |
| Säwe, J | 1 |
| Quaschning, T | 1 |
| Mainka, T | 1 |
| Nauck, M | 1 |
| Rump, LC | 1 |
| Wanner, C | 1 |
| Krämer-Guth, A | 1 |
| Manu, M | 1 |
| Tanabe, K | 1 |
| Tokumoto, T | 1 |
| Ishikawa, N | 1 |
| Shimizu, T | 1 |
| Okuda, H | 1 |
| Ito, S | 1 |
| Shimmura, H | 1 |
| Inui, M | 1 |
| Harano, M | 1 |
| Shiroyanagi, Y | 1 |
| Yagisawa, T | 1 |
| Fuchinoue, S | 1 |
| Toma, H | 1 |
2 trials available for azathioprine and Hypertriglyceridemia
| Article | Year |
|---|---|
Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Drug Therapy, Combination; France; Graft Reject | 2003 |
Immunosuppression enhances atherogenicity of lipid profile after transplantation.
Topics: Apolipoproteins B; Arteriosclerosis; Azathioprine; Cholesterol, VLDL; Cyclosporine; Drug Therapy, Co | 1999 |
3 other studies available for azathioprine and Hypertriglyceridemia
| Article | Year |
|---|---|
Lipid profile before and after renal transplantation--a longitudinal study.
Topics: Adult; Azathioprine; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cyclosporine | 2003 |
Hypertriglyceridemia in renal transplant recipients treated with sirolimus.
Topics: Adult; Aged; Azathioprine; Cholesterol; Drug Therapy, Combination; Humans; Hypertriglyceridemia; Imm | 1998 |
Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience.
Topics: Adult; Azathioprine; Cholesterol; Cholesterol, HDL; Cyclosporine; Drug Therapy, Combination; Female; | 2000 |